Literature DB >> 3923514

Chronic haloperidol during development attenuates dopamine autoreceptor function in striatal and mesolimbic brain regions of young and older adult rats.

F M Scalzo, L P Spear.   

Abstract

The effects of chronic haloperidol administration during the prenatal and preweanling periods on dopamine autoreceptor function were examined in striatum, olfactory tubercles, and nucleus accumbens of young (2-3 month) and older (12-13 month) adult rats. In striatum of young and older adult rats that had been chronically treated with haloperidol early in life, as well as in the nucleus accumbens of older adults receiving early chronic haloperidol, gamma-butyrolactone (GBL) did not induce significant increases in dopamine levels. In olfactory tubercles of young adults that had received early chronic treatment with haloperidol, apomorphine pretreatment failed to reverse the observed GBL-induced increase in dopamine levels. Thus, dopamine autoreceptor function appears to be attenuated in rats chronically treated with haloperidol during early development, in contrast to reports of autoreceptor supersensitivity following neuroleptic treatment in adulthood.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3923514     DOI: 10.1007/bf00428186

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  A SENSITIVE METHOD FOR SPECTROPHOTOFLUOROMETRIC ASSAY OF CATECHOLAMINES.

Authors:  C C CHANG
Journal:  Int J Neuropharmacol       Date:  1964-12

2.  The effect of intracerebroventricularly administered GABA on brain monoamine metabolism.

Authors:  B Biswas; A Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-08       Impact factor: 3.000

3.  [3H]Haloperidol and [3H]spiroperidol binding in rat striatum during ageing.

Authors:  S Govoni; P F Spano; M Trabucchi
Journal:  J Pharm Pharmacol       Date:  1978-07       Impact factor: 3.765

Review 4.  Formation and maintenance of synaptic connections in autonomic ganglia.

Authors:  D Purves; J W Lichtman
Journal:  Physiol Rev       Date:  1978-10       Impact factor: 37.312

5.  Regional mapping of neostriatal neurotransmitter systems as a function of aging.

Authors:  R Strong; T Samorajski; Z Gottesfeld
Journal:  J Neurochem       Date:  1982-09       Impact factor: 5.372

6.  Acute and chronic ethanol ingestion and serotonin metabolism in rat brain.

Authors:  L A Pohorecky; B Newman; J Sun; W H Bailey
Journal:  J Pharmacol Exp Ther       Date:  1978-02       Impact factor: 4.030

7.  Mesocortical dopamine neurons. Lack of autoreceptors modulating dopamine synthesis.

Authors:  M J Bannon; R L Michaud; R H Roth
Journal:  Mol Pharmacol       Date:  1981-03       Impact factor: 4.436

8.  Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover.

Authors:  P Lerner; P Nosé; E K Gordon; W Lovenberg
Journal:  Science       Date:  1977-07-08       Impact factor: 47.728

9.  Supersensitivity to dopaminergic agonists induced by haloperidol.

Authors:  J E Thornburg; K E Moore
Journal:  Natl Inst Drug Abuse Res Monogr Ser       Date:  1975-11

10.  Synthesis rate of dopamine: difference between corpus striatum and limbic system as a possible explanation of variations in reactions to drugs.

Authors:  N E Andén; M Grabowska-Andén; S Lindgren; U Thornström
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-07       Impact factor: 3.000

View more
  7 in total

Review 1.  Drugs, biogenic amine targets and the developing brain.

Authors:  Aliya L Frederick; Gregg D Stanwood
Journal:  Dev Neurosci       Date:  2009-04-17       Impact factor: 2.984

2.  Prenatal antipsychotic exposure and neuromotor performance during infancy.

Authors:  Katrina C Johnson; Jamie L LaPrairie; Patricia A Brennan; Zachary N Stowe; D Jeffrey Newport
Journal:  Arch Gen Psychiatry       Date:  2012-08

3.  Delayed yet persistent effects of daily risperidone on activity in developing rats.

Authors:  Rachel M Stevens; Matthew A Gannon; Molly S Griffith; Mark E Bardgett
Journal:  Behav Pharmacol       Date:  2016-08       Impact factor: 2.293

4.  Early-life risperidone administration alters maternal-offspring interactions and juvenile play fighting.

Authors:  Matthew A Gannon; Clifford J Brown; Rachel M Stevens; Molly S Griffith; Cecile A Marczinski; Mark E Bardgett
Journal:  Pharmacol Biochem Behav       Date:  2015-01-17       Impact factor: 3.533

5.  Adult rats treated with risperidone during development are hyperactive.

Authors:  Mark E Bardgett; Julie M Franks-Henry; Kristin R Colemire; Kathleen R Juneau; Rachel M Stevens; Cecile A Marczinski; Molly S Griffith
Journal:  Exp Clin Psychopharmacol       Date:  2013-06       Impact factor: 3.157

6.  Fluoxetine exposure in adolescent and adult female mice decreases cocaine and sucrose preference later in life.

Authors:  Francisco J Flores-Ramirez; Israel Garcia-Carachure; David O Sanchez; Celene Gonzalez; Samuel A Castillo; Miguel A Arenivar; Anapaula Themann; Omar Lira; Minerva Rodriguez; Joshua Preciado-Piña; Sergio D Iñiguez
Journal:  J Psychopharmacol       Date:  2018-10-18       Impact factor: 4.153

7.  Prenatal Exposure to Antipsychotics Disrupts the Plasticity of Dentate Neurons and Memory in Adult Male Mice.

Authors:  Han Wang; Ji-Tao Li; Yue Zhang; Rui Liu; Xiao-Dong Wang; Tian-Mei Si; Yun-Ai Su
Journal:  Int J Neuropsychopharmacol       Date:  2019-01-01       Impact factor: 5.176

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.